Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021

SELL
$61.91 - $67.42 $16.7 Million - $18.2 Million
-270,300 Closed
0 $0
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $6.57 Million - $7.39 Million
-110,700 Reduced 29.06%
270,300 $17.1 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $808,360 - $916,020
-14,000 Reduced 3.54%
381,000 $23.6 Million
Q2 2020

Jul 23, 2020

BUY
$54.82 - $64.09 $13.3 Million - $15.5 Million
242,100 Added 158.34%
395,000 $23.2 Million
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $7.09 Million - $10.3 Million
152,900 New
152,900 $8.52 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Adams Diversified Equity Fund, Inc. Portfolio

Follow Adams Diversified Equity Fund, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.